Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Tacheva (Stara Zagora, Bulgaria), D. Dimov (Stara Zagora, Bulgaria), Y. Zhelyazkova (Stara Zagora, Bulgaria), M. Zafar (Stara Zagora, Bulgaria), T. Tatyana (Stara Zagora, Bulgaria). Investigation of possible role of serum fibulin as biomarker of COPD.. 565

Member's Comments

No comment yet.

Related content which might interest you: Visfatin as a possible serum biomarker in COPD Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 A novel serum biomarker of type XXVIII collagen turnover is elevated in lung cancer but not in COPD Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 The role of serum IL6 in stable COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Development of a new sensitive ELISA for the determination in serum of uteroglobin-related protein 1 (UGRP-1), a new potential lung biomarker Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010 A potential role for extracellular matrix proteins in lung ageing in COPD Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019 Year: 2020 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Can YKL-40 be used as a biomarker and therapeutic target for adult asthma? Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017 Year: 2018 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 KL-6 is a useful serum biomarker for early detection of interstitial lung disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012